vs

Side-by-side financial comparison of MICROVISION, INC. (MVIS) and Onconetix, Inc. (ONCO). Click either name above to swap in a different company.

Onconetix, Inc. is the larger business by last-quarter revenue ($303.6K vs $223.0K, roughly 1.4× MICROVISION, INC.). On growth, Onconetix, Inc. posted the faster year-over-year revenue change (-57.4% vs -86.5%). Over the past eight quarters, Onconetix, Inc.'s revenue compounded faster (-34.2% CAGR vs -51.7%).

MicroVision Inc. is a technology company specializing in advanced LiDAR sensors, miniature display solutions, and perception software. Its core products serve automotive ADAS, augmented reality devices, consumer electronics, and industrial automation markets, delivering high-precision, low-power sensing technologies for next-generation smart applications.

Onconetix, Inc. is a clinical-stage biopharmaceutical firm developing innovative targeted therapies for underserved cancer patients. Its pipeline includes candidates for hard-to-treat solid tumors, operating mainly across North American and global oncology markets, prioritizing treatments with superior safety and efficacy over existing standard care options.

MVIS vs ONCO — Head-to-Head

Bigger by revenue
ONCO
ONCO
1.4× larger
ONCO
$303.6K
$223.0K
MVIS
Growing faster (revenue YoY)
ONCO
ONCO
+29.1% gap
ONCO
-57.4%
-86.5%
MVIS
Faster 2-yr revenue CAGR
ONCO
ONCO
Annualised
ONCO
-34.2%
-51.7%
MVIS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MVIS
MVIS
ONCO
ONCO
Revenue
$223.0K
$303.6K
Net Profit
$5.7M
Gross Margin
81.6%
Operating Margin
-422.1%
Net Margin
1867.5%
Revenue YoY
-86.5%
-57.4%
Net Profit YoY
-21.2%
119.3%
EPS (diluted)
$-5.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MVIS
MVIS
ONCO
ONCO
Q4 25
$223.0K
$303.6K
Q3 25
$241.0K
$303.7K
Q2 25
$155.0K
$106.5K
Q1 25
$589.0K
$101.6K
Q4 24
$1.6M
$712.0K
Q3 24
$190.0K
$406.9K
Q2 24
$1.9M
$704.8K
Q1 24
$956.0K
$700.4K
Net Profit
MVIS
MVIS
ONCO
ONCO
Q4 25
$5.7M
Q3 25
$-14.2M
$-8.8M
Q2 25
$-14.2M
$-2.4M
Q1 25
$-28.8M
$-8.5M
Q4 24
$-31.2M
$-29.4M
Q3 24
$-15.5M
$-3.8M
Q2 24
$-23.9M
$-14.3M
Q1 24
$-26.3M
$-11.1M
Gross Margin
MVIS
MVIS
ONCO
ONCO
Q4 25
81.6%
Q3 25
88.6%
Q2 25
66.2%
Q1 25
6.6%
45.1%
Q4 24
-149.5%
92.7%
Q3 24
25.9%
Q2 24
18.2%
14.3%
Q1 24
-33.6%
27.0%
Operating Margin
MVIS
MVIS
ONCO
ONCO
Q4 25
-422.1%
Q3 25
-5278.4%
-681.5%
Q2 25
-9455.5%
-1817.4%
Q1 25
-2383.7%
-12369.2%
Q4 24
-1119.5%
-4093.7%
Q3 24
-8266.3%
-650.3%
Q2 24
-1296.4%
-1931.6%
Q1 24
-2793.9%
-1582.2%
Net Margin
MVIS
MVIS
ONCO
ONCO
Q4 25
1867.5%
Q3 25
-5899.2%
-2892.7%
Q2 25
-9180.0%
-2227.8%
Q1 25
-4886.1%
-8408.8%
Q4 24
-1888.2%
-4134.7%
Q3 24
-8166.8%
-940.7%
Q2 24
-1259.5%
-2029.8%
Q1 24
-2752.4%
-1587.4%
EPS (diluted)
MVIS
MVIS
ONCO
ONCO
Q4 25
$-5.02
Q3 25
$-0.05
$-6.25
Q2 25
$-0.06
$-4.76
Q1 25
$-0.12
$-0.53
Q4 24
$-0.15
$637.36
Q3 24
$-0.07
$-249.08
Q2 24
$-0.11
$-2191.59
Q1 24
$-0.13
$-20.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MVIS
MVIS
ONCO
ONCO
Cash + ST InvestmentsLiquidity on hand
$74.9M
Total DebtLower is stronger
$19.2M
Stockholders' EquityBook value
$55.5M
$15.8M
Total Assets
$103.1M
$24.9M
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MVIS
MVIS
ONCO
ONCO
Q4 25
$74.9M
Q3 25
$99.5M
Q2 25
$91.4M
Q1 25
$69.0M
Q4 24
$74.7M
Q3 24
$43.2M
Q2 24
$56.6M
Q1 24
$73.1M
Total Debt
MVIS
MVIS
ONCO
ONCO
Q4 25
$19.2M
Q3 25
$29.0M
Q2 25
$32.3M
Q1 25
$30.1M
Q4 24
$33.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MVIS
MVIS
ONCO
ONCO
Q4 25
$55.5M
$15.8M
Q3 25
$90.7M
$3.4M
Q2 25
$77.1M
$5.9M
Q1 25
$53.2M
$4.0M
Q4 24
$48.8M
$8.5M
Q3 24
$65.9M
$33.9M
Q2 24
$78.7M
$-35.8M
Q1 24
$93.8M
$-21.5M
Total Assets
MVIS
MVIS
ONCO
ONCO
Q4 25
$103.1M
$24.9M
Q3 25
$150.8M
$19.7M
Q2 25
$140.6M
$19.1M
Q1 25
$116.7M
$18.8M
Q4 24
$121.2M
$28.2M
Q3 24
$88.3M
$61.9M
Q2 24
$103.4M
$59.5M
Q1 24
$124.2M
$75.0M
Debt / Equity
MVIS
MVIS
ONCO
ONCO
Q4 25
0.35×
Q3 25
0.32×
Q2 25
0.42×
Q1 25
0.57×
Q4 24
0.68×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MVIS
MVIS
ONCO
ONCO
Operating Cash FlowLast quarter
$-58.7M
$-3.1M
Free Cash FlowOCF − Capex
$-59.4M
FCF MarginFCF / Revenue
-26636.3%
Capex IntensityCapex / Revenue
304.5%
Cash ConversionOCF / Net Profit
-0.55×
TTM Free Cash FlowTrailing 4 quarters
$-103.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MVIS
MVIS
ONCO
ONCO
Q4 25
$-58.7M
$-3.1M
Q3 25
$-16.5M
$-3.2M
Q2 25
$-12.7M
$-1.4M
Q1 25
$-14.1M
$-2.0M
Q4 24
$-15.1M
$-917.6K
Q3 24
$-14.1M
$-1.1M
Q2 24
$-18.6M
$-3.2M
Q1 24
$-20.8M
$-5.2M
Free Cash Flow
MVIS
MVIS
ONCO
ONCO
Q4 25
$-59.4M
Q3 25
$-16.6M
Q2 25
$-12.9M
Q1 25
$-14.2M
Q4 24
$-15.2M
$-921.5K
Q3 24
$-14.1M
$-1.1M
Q2 24
$-18.8M
$-3.2M
Q1 24
$-20.9M
$-5.2M
FCF Margin
MVIS
MVIS
ONCO
ONCO
Q4 25
-26636.3%
Q3 25
-6894.6%
Q2 25
-8346.5%
Q1 25
-2410.4%
Q4 24
-918.7%
-129.4%
Q3 24
-7421.1%
-282.4%
Q2 24
-989.5%
-456.4%
Q1 24
-2183.4%
-747.6%
Capex Intensity
MVIS
MVIS
ONCO
ONCO
Q4 25
304.5%
Q3 25
53.1%
Q2 25
134.2%
Q1 25
16.8%
Q4 24
6.2%
0.5%
Q3 24
4.7%
0.6%
Q2 24
8.7%
2.5%
Q1 24
11.9%
0.7%
Cash Conversion
MVIS
MVIS
ONCO
ONCO
Q4 25
-0.55×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons